Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRDX1 | Q06830 | 16/20 | 0.67 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.62 |
| ▸ | TERT | O14746 | 1/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22010877 | 0.91 | PRDX1 (0.63) | PRDX1NR4A1TERTPTPN1CASP1 | |
| SCHEMBL18781890 | 0.90 | PRDX1 (0.80) | PRDX1NR4A1TERTPTPN1CASP1 | |
| SCHEMBL22010609 | 0.89 | PRDX1 (0.68) | PRDX1NR4A1 | |
| SCHEMBL22011631 | 0.87 | PRDX1 (0.57) | PRDX1NR4A1TERTPTPN1CASP1 | |
| SCHEMBL22011087 | 0.87 | NR4A1 (0.81) | PRDX1NR4A1TERTPTPN1CASP1 | |
| SCHEMBL21529185 | 0.85 | NR4A1 (0.78) | NR4A1TERTPTPN1CASP1ABHD6 | |
| SCHEMBL22010874 | 0.83 | HSP90AA1 (0.77) | NR4A1TERTPTPN1CASP1ABHD6 | |
| SCHEMBL23490905 | 0.83 | NR4A1 (0.70) | PRDX1NR4A1TERTPTPN1CASP1 | |
| SCHEMBL22010584 | 0.83 | TERT (0.79) | NR4A1TERTPTPN1CASP1ABHD6 | |
| SCHEMBL22011634 | 0.83 | NR4A1 (0.79) | PRDX1NR4A1TERTPTPN1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753436-B2 | Analogs of celastrol | ERX PHARMACEUTICALS CORPORATION (US) | 2023-09-12 | — | — | US | disclosed |
| US-10662218-B2 | Analogs of celastrol | ERX PHARMACEUTICALS CORPORATION | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662218-B2 | Analogs of celastrol | GIPR, GPR119, EBP | PRDX1 4176/4885NR4A1 1945/4885TERT 3225/4885 |
| US-11753436-B2 | Analogs of celastrol | GIPR, GPR119, EBP | PRDX1 4176/4885NR4A1 1945/4885TERT 3225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.